TCR-mediated phosphorylation of STAT3 has previously been shown to be enhanced in CD4+ Teffs from patients with T1D compared with healthy control individuals, suggesting altered kinetics of STAT3 activation in patients with T1D (13). This evidence concerns the gene STAT3 and type 1 diabetes mellitus.